The Global Pain Pharmaceutical Market Analysis and Forecasts 2007-2022

The global pain pharmaceutical market is set to become a serious growth area experiencing a compound annual growth rate of 4.56% to 2012. Visiongain's latest report, "The Global Pain Pharmaceutical Market 2007-2022 ", explains just how this market will experience growth over the medium term future. The report also highlights forecast for 2022, so that you and your company can make longer term plans. Don't let your competitors get the head-start on you, order this report today.

Key questions answered in this report

1. Current and future key products that will drive the pain market

2. The affects of patent expiry on key blockbuster drugs within the pain market

3. How the withdrawal of COX-2 inhibitors impacted the pain market.

4. The key companies involved in the industry, in terms of current and future aims and objectives.

5. How the safety of the narcotic drugs have affected the market

6. The affects of reformulations of existing and new drugs on the market

The world market is currently valued at $31.1bn and revenues are forecasted to increase just under $40bn in 2012. But what will it be in 2022? This report tells you. Do you know what the drivers and restraints of the market are? This report not only reveals these, but also details what strategies can be used to maximize profits from the drivers and restraints in terms of a SWOT analysis. Ensure your organisation is successful in this market by reserving your copy of visiongain's report today.

According to the findings of the new 135+ page report, visiongain reveals that the non-narcotics market is set to dominate the pain market over the forecast period (2007-2012), accounting for almost 36.8% of market revenues by 2012. This market is set for growth right through the next 15 years and this report will help you plan. Reserve your copy today.

Find out who are the major companies involved in the pain market today and in the future. And what R&D opportunities exist for 'new-comers' to the pain pharmaceutical market. Analyse the pipeline of pain products and how it effects your future product launches and partners.

In the process of providing a thorough evaluation of the market, the visiongain pain report focuses on the major market areas including:

1. Anti-Migraine market

2. Anti-Rheumatics non-steroidal market

3. Narcotics market

4. Non-narcotics market

Do you know what the market values of these major therapeutic areas of the pain market are? You should, and this report will tell you.

Plus in-depth analysis of companies, product pipelines and strategies of:

- Pfizer

- Johnson & Johnson (J&J)

- GlaxoSmithKline (GSK)

- MundiPharma

- Novartis

The report provides in-depth market analysis upon these areas, and extensively identifies both prescription and OTC pain drugs by disease and product type. The report also focuses on the technological issues, including the latest trends, patents, new products and other influential factors. The study also assesses the challenges faced by companies in the pain industry, and what exciting market opportunities exist in this up- and-coming therapeutic area.

Why You Must Buy This Report?

This report features news, insights, the latest developments and an in depth survey of the pain market with up-to-date analysis as well as over 50 tables, graphs and charts. This report is a vital addition to gaining an understanding of this highly profitable market sector and will give your company 'the edge' on your competitors. You can not afford to be without this latest report from visiongain.

Unique benefits to you when you order this report

- You can access your report whichever country you are in without using harddrive space

- Primary research throughout. You will not find this information anywhere else

- Report stored in your reading room for ever

- Full searchable report when you buy the company or corporate editions

- Copies can be printed off for offline reading

- Packed with charts, analysis, figures, graphs and tables

Publication date: 27-9-07

Pages: 132
Table of Contents
Sample Pages

Price
Single User Licence $2995.00
Department Licence 5 Users $5995.00
Company-wide Intranet Licence $9995.00